Here’s the latest instalment in our news updates from Blackford Platform Partners.
Imaging AI specialist icometrix highlighted the publication of a recent study of commercially available AI software products, which showed that only 36 out of 100 products have peer-reviewed evidence supporting them. The company has also teamed up with Stanford University to identify differences in structural biomarkers and imaging predictors of global cognitive severity.
In addition, icometrix announced the launch of ALZimaging, an independent educational platform on current and future paradigms of neuroimaging in the management of Alzheimer’s Disease.
AI-powered breast health solution provider Densitas announced the deployment of its intelliMammo A.I. platform across Canada’s Maritime Provinces. The company also announced it is sponsoring a free webinar with Mammography Educators later this month.
Neurovascular emergency AI specialist Avicenna.AI announced the publication of a new clinical study validating the use of its CINA software as a deep learning tool in the detection of intracranial hemorrhage and large vessel occlusion.
Visualization and analytical solutions developer Imaging Biometrics announced that it is sponsoring a Phase 1 clinical trial using an orally bioavailable agent to treat glioblastoma (GBM). The company is providing its IB Clinic brain tumour assessment software to help measure tumour progression.
In addition, Imaging Biometrics announced that one of its customers, Dr Mark Shiroishi, will be delivering a video lecture on Perfusion MRI of Brain Tumors later this month.
Medical imaging enhancement specialist Subtle Medical published a new blog highlighting the company’s goal to accelerate faster, safer, and smarter medical imaging worldwide and its key relationship with Nvidia for product development. The company’s SubtleMR AI technology was also featured in this Applied Radiology article.
Medical diagnostic provider MaxQ AI secured registration from the UAE’s Ministry of Health and Prevention for Accipio Ix, Accipio Ax, and Accipio Dxg.
Lung analysis firm VIDA released its texture analysis feature, which provides quantitative measures and distribution of ground glass/reticulation, consolidation and honeycombing. The company also hosted a webinar interview with pulmonologist and author Michael J. Stephen, MD.
Stay tuned for more partner news next month!